| Old Articles: <Older 26631-26640 Newer> |
 |
The Motley Fool October 15, 2007 Anders Bylund |
BEA Plays a Fool's Game A multi-billion-dollar bidding war is about to start. Or is it? Buying BEA stock today is a gamble that the company's price tag will grow before an eventual sale. A sensible investor might take the gains here and go look for a safer bet.  |
The Motley Fool October 15, 2007 Brian Lawler |
A Surprising Decision for Telik It still doesn't look like the pharma's lead drug is helping anyone get better. Investors, take note.  |
The Motley Fool October 15, 2007 Rich Duprey |
Beazer Tries Po' Boy Routine The homebuilder seeks forbearance on debt covenants to avoid default. Investors, take note.  |
The Motley Fool October 15, 2007 Rick Aristotle Munarriz |
China Can Get Hotter It was another huge week of Chinese winners. Sooner or later, the nation's red-hot stocks will bump against a ceiling, realize what they've done, and correct accordingly. It will happen. It's just not happening now.  |
The Motley Fool October 15, 2007 Rich Smith |
Pepsi Loses Some Fizz The quarter was good for the soda giant. It's the quarter ahead that must be causing some nervousness.  |
The Motley Fool October 15, 2007 Alyce Lomax |
Hot Topic's Conformist Comps In September, Hot Topic didn't stand out in the crowd. Investors, take note.  |
The Motley Fool October 15, 2007 Rick Aristotle Munarriz |
Mattel Has Toys in the Attic Toy sales keep going the wrong way at Mattel. The toymaker posted sluggish third-quarter reports this morning, but that's just the tip of iceberg.  |
The Motley Fool October 15, 2007 Dan Bloom |
Another Fab Diet The semiconductor manufacturer Atmel announces the sale of another wafer fabrication facility in the UK, which brings it closer to its goal of streamlining its operations. Investors, take note.  |
The Motley Fool October 15, 2007 Tom Taulli |
Activist Shareholder Stalks Sybase A hedge fund is pushing the enterprise-software operator for a sale. Investors, take note.  |
The Motley Fool October 15, 2007 Brian Lawler |
Save Your Cash, Pfizer A multibillion-dollar stake in Sanofi wouldn't fix Pfizer's problems. Investors, take note.  |
| <Older 26631-26640 Newer> Return to current articles. |